NCT05340530 - To Evaluate the Pharmacokinetic Effects of TQD3606 for Injection in Healthy Adult Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2022

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions

Infections

Interventions

DRUG

The injectable TQD3606

TQD3606 is a fixed-dose combination of meropenem and avibatam.

DRUG

meropenem

Meropenem is a carbapenem antibiotic

DRUG

Avibactam Sodium

Avibactam is beta-lactamase inhibitor.

DRUG

Placebo

It is a placebo.

Trial Locations (1)

Affiliated Hospital of Changchun University of Traditional Chinese Medicine, Changchun